mitoxantrone in combination with vp-16 proved to be effective in refractory and relapsed acute myeloid leukemia ( aml ) , with 42 % of patients achieving complete remission ( cr ) .
C0026259
mitoxantrone
C0023467
acute myeloid leukemia